UNSPSC 85742022: Removal of infusion device from fallopian tube, external approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of infusion device from fallopian tube, external approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0UP8X3Z

UNSPSC 85742022 Removal of infusion device from fallopian tube, external approach is a Commodity code that shows little relevant recent activity in state and local procurement. The code's nominal scope—a surgical procedure for removing a contraceptive device—does not align with the state and local solicitations tagged under it. Recent opportunities under this code address occupational medical surveillance, disability medical evaluations, surgical benefit networks, pharmacy benefit management, temporary health professional staffing, and youth detention healthcare services. None of these procurements involve infusion device removal or the specific clinical procedure the code describes. State and local procurement systems occasionally misclassify or broadly apply UNSPSC codes to healthcare-related solicitations without precision matching to commodity-level definitions, and this code appears to be a case of that mismatch.

The issuing bodies posting under this code span state health systems (Washington State Department of Transportation's ferry operations, County of Santa Clara Health System), county government (Collier County, Harris County), and municipal entities (City of Phoenix Retirement Office, City of Long Beach), with activity concentrated in Arizona, California, Florida, and Washington. No repeat buyers emerge across the recent opportunities. The most substantive recent posting—the Washington State Department of Transportation's occupational medical surveillance RFP due October 9, 2026—seeks baseline and periodic medical examinations for ferry workers across 14 Washington locations, evaluated at 40 percent cost weighting and 60 percent capability factors. Given the code's abstract definition and the absence of actual infusion-device or gynecological-procedure procurement, this code warrants low priority for vendors focused on the surgical device or procedure market.